The mTOR pathway, a key signaling pathway for initiating metabolic reprogramming,[16] is closely related to the occurrence and development of colon cancer.[56] It also promotes the expression of G6PD in an SREBF1‐dependent manner in HEK293 cells. Here, G6PD is linked to malignant colon neoplasm.